18,258 Shares in Stoke Therapeutics, Inc. (NASDAQ:STOK) Acquired by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 18,258 shares of the company’s stock, valued at approximately $201,000. Other large investors […]
Tudor Investment Corp ET AL bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 18,258 shares of the company’s stock, valued at approximately $201,000. Other large investors […]
